75 related articles for article (PubMed ID: 23853312)
1. Association of epigenetic alterations in the human C7orf24 gene with the aberrant gene expression in malignant cells.
Ohno Y; Hattori A; Yoshiki T; Kakeya H
J Biochem; 2013 Oct; 154(4):355-62. PubMed ID: 23853312
[TBL] [Abstract][Full Text] [Related]
2. Multiple NF-Y-binding CCAAT boxes are essential for transcriptional regulation of the human C7orf24 gene, a novel tumor-associated gene.
Ohno Y; Hattori A; Ueda M; Kageyama S; Yoshiki T; Kakeya H
FEBS J; 2011 Nov; 278(21):4088-99. PubMed ID: 21883928
[TBL] [Abstract][Full Text] [Related]
3. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
[TBL] [Abstract][Full Text] [Related]
4. Proteomic profiling of mammary carcinomas identifies C7orf24, a gamma-glutamyl cyclotransferase, as a potential cancer biomarker.
Gromov P; Gromova I; Friis E; Timmermans-Wielenga V; Rank F; Simon R; Sauter G; Moreira JM
J Proteome Res; 2010 Aug; 9(8):3941-53. PubMed ID: 20527979
[TBL] [Abstract][Full Text] [Related]
5. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
Zhang Y; Fatima N; Dufau ML
Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
[TBL] [Abstract][Full Text] [Related]
6. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
7. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
Hinshelwood RA; Melki JR; Huschtscha LI; Paul C; Song JZ; Stirzaker C; Reddel RR; Clark SJ
Hum Mol Genet; 2009 Aug; 18(16):3098-109. PubMed ID: 19477956
[TBL] [Abstract][Full Text] [Related]
8. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.
Magdinier F; Wolffe AP
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4990-5. PubMed ID: 11309512
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic inactivation of the placentally imprinted tumor suppressor gene TFPI2 in prostate carcinoma.
Ribarska T; Ingenwerth M; Goering W; Engers R; Schulz WA
Cancer Genomics Proteomics; 2010; 7(2):51-60. PubMed ID: 20335518
[TBL] [Abstract][Full Text] [Related]
10. Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer.
Soejima H; Nakagawachi T; Zhao W; Higashimoto K; Urano T; Matsukura S; Kitajima Y; Takeuchi M; Nakayama M; Oshimura M; Miyazaki K; Joh K; Mukai T
Oncogene; 2004 May; 23(25):4380-8. PubMed ID: 15007390
[TBL] [Abstract][Full Text] [Related]
11. Reversible epigenetic fingerprint-mediated glutathione-S-transferase P1 gene silencing in human leukemia cell lines.
Karius T; Schnekenburger M; Ghelfi J; Walter J; Dicato M; Diederich M
Biochem Pharmacol; 2011 Jun; 81(11):1329-42. PubMed ID: 21453686
[TBL] [Abstract][Full Text] [Related]
12. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene.
Strathdee G; Davies BR; Vass JK; Siddiqui N; Brown R
Carcinogenesis; 2004 May; 25(5):693-701. PubMed ID: 14729589
[TBL] [Abstract][Full Text] [Related]
13. Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation.
Li X; Liu J; Zhou R; Huang S; Huang S; Chen XM
Br J Haematol; 2010 Jan; 148(1):69-79. PubMed ID: 19807731
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.
Taniguchi H; Yamamoto H; Akutsu N; Nosho K; Adachi Y; Imai K; Shinomura Y
J Pathol; 2007 Oct; 213(2):131-9. PubMed ID: 17724792
[TBL] [Abstract][Full Text] [Related]
15. The mRNA distribution of C7orf24, a gamma-glutamyl cyclotransferase, in rat tissues.
Oda K; Makino S; Masuda C; Yoshiki T; Kitamura Y; Takata K; Yanagisawa D; Taniguchi T; Tooyama I
J Histochem Cytochem; 2009 Dec; 57(12):1121-6. PubMed ID: 19687470
[TBL] [Abstract][Full Text] [Related]
16. Prevention of tumor growth by needle-free jet injection of anti-C7orf24 siRNA.
Hama S; Arata M; Nakamura I; Kasetani T; Itakura S; Tsuchiya H; Yoshiki T; Kogure K
Cancer Gene Ther; 2012 Aug; 19(8):553-7. PubMed ID: 22653386
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
Stirzaker C; Song JZ; Davidson B; Clark SJ
Cancer Res; 2004 Jun; 64(11):3871-7. PubMed ID: 15172996
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma.
Spugnardi M; Tommasi S; Dammann R; Pfeifer GP; Hoon DS
Cancer Res; 2003 Apr; 63(7):1639-43. PubMed ID: 12670917
[TBL] [Abstract][Full Text] [Related]
19. [C7orf24/gamma-glutamyl cyclotransferase as a molecular target for cancer chemotherapy].
Ohno Y; Hattori A; Kakeya H
Nihon Rinsho; 2012 Nov; 70 Suppl 8():723-7. PubMed ID: 23513927
[No Abstract] [Full Text] [Related]
20. Involvement of cancer biomarker C7orf24 in the growth of human osteosarcoma.
Uejima D; Nishijo K; Kajita Y; Ishibe T; Aoyama T; Kageyama S; Iwaki H; Nakamura T; Iida H; Yoshiki T; Toguchida J
Anticancer Res; 2011 Apr; 31(4):1297-305. PubMed ID: 21508379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
